Edwards Lifesciences Corp Annual Operating Lease, Payments in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Edwards Lifesciences Corp quarterly/annual Operating Lease, Payments history and growth rate from 2018 to 2023.
  • Edwards Lifesciences Corp Operating Lease, Payments for the quarter ending March 31, 2024 was $8.2M, a 15.5% increase year-over-year.
  • Edwards Lifesciences Corp annual Operating Lease, Payments for 2023 was $28.8M, a 2.49% increase from 2022.
  • Edwards Lifesciences Corp annual Operating Lease, Payments for 2022 was $28.1M, a 11.9% decline from 2021.
  • Edwards Lifesciences Corp annual Operating Lease, Payments for 2021 was $31.9M, a 7.41% increase from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $28.8M +$700K +2.49% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-12
2022 $28.1M -$3.8M -11.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-12
2021 $31.9M +$2.2M +7.41% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-12
2020 $29.7M +$1.1M +3.85% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-13
2019 $28.6M +$28.6M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-14
2018 $0 Jan 1, 2018 Dec 31, 2018 10-K 2021-02-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.